PACB stock forecast
Our latest prediction for Pacific Biosciences of California, Inc.'s stock price was made on the Feb. 19, 2020 when the stock price was at 4.49$.
In the short term (2weeks), PACB's stock price should underperform the market by -2.86%. During that period the price should oscillate between -10.19% and +10.21%.
In the medium term (3months), PACB's stock price should underperform the market by -6.96%. During that period the price should oscillate between -40.05% and +26.01%.Get email alerts
About Pacific Biosciences of California, Inc.
Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. It operates through the following geographical segments: North America, Europe, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.
At the moment the company generates 91M USD in revenues.
On its last earning announcement, the company reported a loss of -0.55$ per share.
The book value per share is 0.65$
Three months stock forecastFeb. 19, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|